These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33804458)

  • 1. MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc.
    Anastasiadou E; Messina E; Sanavia T; Mundo L; Farinella F; Lazzi S; Megiorni F; Ceccarelli S; Pontecorvi P; Marampon F; Di Gioia CRT; Perniola G; Panici PB; Leoncini L; Trivedi P; Lenzi A; Marchese C
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin Gamma Catalytic Subunit PPP3CC Inhibition by miR-200c-3p Affects Apoptosis in Epithelial Ovarian Cancer.
    Anastasiadou E; Messina E; Sanavia T; Labruna V; Ceccarelli S; Megiorni F; Gerini G; Pontecorvi P; Camero S; Perniola G; Venneri MA; Trivedi P; Lenzi A; Marchese C
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice.
    Yang C; Li H; Zhang T; Chu Y; Chen D; Zuo J
    J Cell Biochem; 2020 Feb; 121(2):1514-1523. PubMed ID: 31535411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
    Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.
    Vescarelli E; Gerini G; Megiorni F; Anastasiadou E; Pontecorvi P; Solito L; De Vitis C; Camero S; Marchetti C; Mancini R; Benedetti Panici P; Dominici C; Romano F; Angeloni A; Marchese C; Ceccarelli S
    J Exp Clin Cancer Res; 2020 Jan; 39(1):3. PubMed ID: 31898520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
    Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
    Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Role of miR-200c-3p in High-Grade Serous Ovarian Cancer Progression via Targeting the 3'-Untranslated Region of DLC1.
    Ankasha SJ; Shafiee MN; Abdul Wahab N; Raja Ali RA; Mokhtar NM
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
    Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation.
    Liu Y; Li L; Wang X; Wang P; Wang Z
    J Ovarian Res; 2020 May; 13(1):60. PubMed ID: 32414422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4.
    Du SY; Huang XX; Li NM; Lv CY; Lv CH; Wei ML; Gao Z; Zhang YP
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10383-10390. PubMed ID: 33155194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
    Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway.
    Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C
    Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.